Simultaneous Eye-safe Spectroscopy and Fundus Imaging Technology for Point-of-Care Detection of Traumatic Brain Injury
用于即时检测脑外伤的同时人眼安全光谱和眼底成像技术
基本信息
- 批准号:EP/Y030206/1
- 负责人:
- 金额:$ 212.28万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2023
- 资助国家:英国
- 起止时间:2023 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Millions of people world-wide die from late diagnosis every year. In particular, in emergency care practice, life- critical decisions must be made rapidly, influencing patients' prognosis and the efficacy of treatment. There is a critical window for diagnosis of many acute diseases such as, traumatic brain injury (TBI) - a leading cause of morbidity and mortality worldwide. TBI has become a major challenge of the 21st century and by 2028, the WHO estimates that neuro-trauma will become the leading cause of death worldwide. While life-changing decisions must be made rapidly, it is notoriously hard to diagnose at the point-of-care, resulting in incorrect patient management and the chances of an individual suffering cognitive or physical impairment are massively increased. Current diagnostic technologies are woefully inadequate either requiring large equipment, long- waiting times, invasive or not sensitive and timely enough. There is an urgent need for new technologies to achieve timely intervention through rapid and accurate TBI diagnostics at the point-of-care.This research will open new horizons in medical devices by exploring how cutting-edge Engineering methods can enable a platform technology that will lead to next generation of applications in miniaturised sensors, monitoring and pharmaceuticals. Underpinning the topic is the development of pioneering portable technology for instantaneous detection of TBI-specific molecular changes, via simultaneous Raman spectroscopy and fundus imaging, to safely measure proxies of cerebral injury via the neuroretina and optic nerve, thus uniquely providing a window into brain biochemistry. Such disruptive technology will enable the low-cost manufacture of a handheld device for early diagnosis of acute injury, whether at the pitch side in contact sports, or the roadside following traffic accidents, will not only inform correct clinical pathways but also mitigate against death and disability from this devastating disease.
全世界每年有数百万人死于晚期诊断。特别是在急诊护理实践中,必须迅速做出攸关生命的决策,从而影响患者的预后和治疗效果。许多急性疾病的诊断都有一个关键的窗口,例如创伤性脑损伤 (TBI)——这是全世界发病和死亡的主要原因。 TBI 已成为 21 世纪的重大挑战,世界卫生组织估计,到 2028 年,神经创伤将成为全球主要死亡原因。虽然必须迅速做出改变生活的决定,但众所周知,在护理点进行诊断非常困难,导致患者管理不正确,并且个人遭受认知或身体损伤的机会大大增加。目前的诊断技术严重不足,要么需要大型设备、等待时间长、侵入性,要么不够灵敏和及时。迫切需要新技术通过在护理点进行快速、准确的 TBI 诊断来实现及时干预。这项研究将通过探索尖端工程方法如何启用平台技术,为医疗设备开辟新视野。引领微型传感器、监控和制药领域的下一代应用。该主题的基础是开发开创性的便携式技术,通过同步拉曼光谱和眼底成像,即时检测 TBI 特异性分子变化,通过神经视网膜和视神经安全地测量脑损伤的指标,从而为了解大脑生物化学提供了一个独特的窗口。这种颠覆性技术将能够低成本制造用于早期诊断急性损伤的手持设备,无论是在接触运动的球场边,还是在交通事故后的路边,不仅可以提供正确的临床路径,还可以减少死亡和死亡风险。因这种毁灭性疾病而致残。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pola Goldberg Oppenheimer其他文献
Hybrid Raman spectroscopy and artificial neural network algorithm discriminating mycobacterium bovis BCG and members of the order mycobacteriales
混合拉曼光谱和人工神经网络算法区分牛分枝杆菌 BCG 和分枝杆菌目成员
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Michael Macgregor;Paulo De Gomes;Daniel Weston;J. J. Rickard;Pola Goldberg Oppenheimer - 通讯作者:
Pola Goldberg Oppenheimer
Pola Goldberg Oppenheimer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pola Goldberg Oppenheimer', 18)}}的其他基金
A smart, multi-purpose technology for diagnostics, analytics and drug delivery
用于诊断、分析和药物输送的智能多用途技术
- 批准号:
EP/W004593/1 - 财政年份:2021
- 资助金额:
$ 212.28万 - 项目类别:
Research Grant
Window into the Mind: Handheld Spectroscopic Eye-safe Device (EyeD) for Neurodiagnostics
心灵之窗:用于神经诊断的手持式光谱眼安全设备 (EyeD)
- 批准号:
EP/V029983/1 - 财政年份:2021
- 资助金额:
$ 212.28万 - 项目类别:
Research Grant
相似国自然基金
lrp2a调控金鱼脂质代谢和眼睛凸出的分子机制
- 批准号:32302991
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于LMD-ICPMS的金属氧化物纳米颗粒对眼睛炎症模式及组织重塑研究
- 批准号:22176115
- 批准年份:2021
- 资助金额:60 万元
- 项目类别:面上项目
视网膜波在多巴胺调节视网膜和眼睛发育中的作用
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
转录因子CREB调节眼睛晶状体分化的分子机制
- 批准号:81900842
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
转录因子CREB调节眼睛晶状体分化的分子机制
- 批准号:81900842
- 批准年份:2019
- 资助金额:21 万元
- 项目类别:青年科学基金项目
相似海外基金
Transferring Pharmacists' Safe and Efficient Dispensing Know-How: Identifying Reasons for Success of Proficient Pharmacists Based on Eye Gaze Measurement.
传授药剂师安全高效的配药知识:基于眼睛注视测量确定熟练药剂师成功的原因。
- 批准号:
23K04309 - 财政年份:2023
- 资助金额:
$ 212.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
NRI: Toward Safe and Reliable Robotic Eye Examinations
NRI:迈向安全可靠的机器人眼科检查
- 批准号:
10671768 - 财政年份:2023
- 资助金额:
$ 212.28万 - 项目类别:
"ELASER" - Eye-safe LASER cleaning - eliminating water, chemicals and abrasives from cleaning processes
“ELASER” - 人眼安全的激光清洁 - 消除清洁过程中的水、化学品和磨料
- 批准号:
10023233 - 财政年份:2022
- 资助金额:
$ 212.28万 - 项目类别:
Collaborative R&D
Developing multi-specific aptamers for safe, potent, and long-lasting treatment of geographic atrophy
开发多特异性适体以安全、有效且持久地治疗地理萎缩
- 批准号:
10482569 - 财政年份:2022
- 资助金额:
$ 212.28万 - 项目类别:
Elucidation of the "eye" for safe endoscopic surgery and construction of a foundation for the technological application
阐明安全内镜手术的“眼睛”,构建技术应用基础
- 批准号:
22K08720 - 财政年份:2022
- 资助金额:
$ 212.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)